Sanofi Faces EU Probe Over Influenza Vaccine Marketing Claims
EU probes Sanofi over alleged misleading flu‑vaccine ads, risking up to 10% fine and impacting investor confidence. Learn how the case could reshape pharma marketing.
2 minutes to read
SANOFI